RAPT Therapeutics Inc (RAPT)
1.565
-0.14
(-8.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Max Drawdown (5Y): 96.63% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 96.63% |
| September 30, 2024 | 96.40% |
| August 31, 2024 | 95.79% |
| July 31, 2024 | 94.43% |
| June 30, 2024 | 94.09% |
| May 31, 2024 | 91.92% |
| April 30, 2024 | 85.94% |
| March 31, 2024 | 85.94% |
| February 29, 2024 | 85.94% |
| January 31, 2024 | 79.00% |
| December 31, 2023 | 79.00% |
| November 30, 2023 | 79.00% |
| October 31, 2023 | 79.00% |
| September 30, 2023 | 79.00% |
| August 31, 2023 | 79.00% |
| July 31, 2023 | 79.00% |
| June 30, 2023 | 79.00% |
| May 31, 2023 | 79.00% |
| April 30, 2023 | 79.00% |
| March 31, 2023 | 79.00% |
| February 28, 2023 | 79.00% |
| January 31, 2023 | 79.00% |
| December 31, 2022 | 79.00% |
| November 30, 2022 | 79.00% |
| October 31, 2022 | 79.00% |
| Date | Value |
|---|---|
| September 30, 2022 | 79.00% |
| August 31, 2022 | 79.00% |
| July 31, 2022 | 79.00% |
| June 30, 2022 | 79.00% |
| May 31, 2022 | 79.00% |
| April 30, 2022 | 75.73% |
| March 31, 2022 | 75.73% |
| February 28, 2022 | 75.73% |
| January 31, 2022 | 75.73% |
| December 31, 2021 | 75.73% |
| November 30, 2021 | 75.73% |
| October 31, 2021 | 75.73% |
| September 30, 2021 | 75.73% |
| August 31, 2021 | 75.73% |
| July 31, 2021 | 75.73% |
| June 30, 2021 | 75.73% |
| May 31, 2021 | 75.73% |
| April 30, 2021 | 75.73% |
| March 31, 2021 | 75.73% |
| February 28, 2021 | 75.73% |
| January 31, 2021 | 75.73% |
| December 31, 2020 | 75.73% |
| November 30, 2020 | 75.73% |
| October 31, 2020 | 75.73% |
| September 30, 2020 | 75.73% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
36.69%
Minimum
Nov 2019
96.63%
Maximum
Oct 2024
77.08%
Average
77.36%
Median
Max Drawdown (5Y) Benchmarks
| Biomarin Pharmaceutical Inc | 52.14% |
| Arbutus Biopharma Corp | 93.95% |
| GlycoMimetics Inc | 97.94% |
| FibroGen Inc | 99.46% |
| Cidara Therapeutics Inc | 95.11% |